Company / Operating Income
DaVita Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$2.0B
FY2025
5-year range
$1.6B / $2.1B
FY2021-FY2025
Trend
-2.2%
vs FY2024
Sector context
#21 of 156
Health Care
What the data says
DaVita's operating income of $2.0B is higher than 87% of companies in the Health Care sector (FY2025). Operating Income has fluctuated over the past 10 years, ranging from $1.5B in FY2020 to $2.1B in FY2024.
Based on SEC 10-K filings.
$2.0B in FY2025 with a 5-year CAGR of +6.0%. Top quartile in the Health Care sector.
Improved from $1.8B to $2.0B over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +6.4%
- 5-Year CAGR
- +6.0%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 156This company $2.0B Sector average $733.1M
▼
+178.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +6.0%, indicating consistent growth.
- In FY2025, operating income decreased 2.2% year-over-year.
- Ranks #21 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.0B | -2.2% |
| FY2024 | $2.1B | +16.3% |
| FY2023 | $1.8B | +6.1% |
| FY2022 | $1.7B | +3.1% |
| FY2021 | $1.6B | +7.7% |
| FY2020 | $1.5B | -15.8% |
| FY2019 | $1.8B | -10.7% |
| FY2018 | $2.0B | +12.0% |
| FY2017 | $1.8B | -10.7% |
| FY2016 | $2.0B | +78.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026